Medication Safety Concerns Surrounding Immunomodulators

被引:0
|
作者
Farber, Margo S. [1 ]
机构
[1] Univ Michigan Hlth Syst, Dept Pharm Serv, Drug Informat Serv, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The number of medications used to manage autoimmune disorders has increased dramatically. These agents-the immunomodulators-have resulted in improvements in patient outcomes and, in some cases, slowing of disease progression. Despite these advances, immunomodulators are also associated with substantial medication-safety concerns. The potential for adverse drug reactions, serious drug-related complications, and medication errors is significant. Pharmacists must be acutely aware of immunomodulators' complexity and associated potential for adverse events. Attention to all aspects of the medication-use process-procurement and storage, prescribing, dispensing, administration, and monitoring-is required to assure that these agents are used in the safest and most efficacious manner.
引用
收藏
页码:HS2 / +
页数:5
相关论文
共 50 条
  • [21] Safety concerns
    不详
    MATERIALS WORLD, 2009, 17 (07) : 20 - 20
  • [22] SAFETY CONCERNS
    WISE, MJ
    INDUSTRIAL ENGINEERING, 1984, 16 (12): : 11 - 11
  • [23] Concerns about medication and medication use in chronic pain
    McCracken, Lance M.
    Hoskins, Julian
    Eccleston, Christopher
    JOURNAL OF PAIN, 2006, 7 (10): : 726 - 734
  • [24] Consumers’ questions about antipsychotic medication: revealing safety concerns and the silent voices of young men
    Rianne A. Weersink
    Katja Taxis
    Treasure M. McGuire
    Mieke L. van Driel
    Social Psychiatry and Psychiatric Epidemiology, 2015, 50 : 725 - 733
  • [25] Cancer Concerns with Topical Immunomodulators in Atopic DermatitisOverview of Data and Recommendations to Clinicians
    Tejesh S. Patel
    Sarah C. Greer
    Robert B. Skinner
    American Journal of Clinical Dermatology, 2007, 8 : 189 - 194
  • [26] Consumers' questions about antipsychotic medication: revealing safety concerns and the silent voices of young men
    Weersink, Rianne A.
    Taxis, Katja
    McGuire, Treasure M.
    van Driel, Mieke L.
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2015, 50 (05) : 725 - 733
  • [27] Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns
    Rick, Jonathan
    Thompson, Alyssa M.
    Hsiao, Jennifer L.
    Liao, Wilson
    Shi, Vivian Y.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1794 - 1797
  • [28] Cancer concerns with topical immunomodulators in atopic dermatitis: Overview of data and recommendations to clinicians
    Patel, Tejesh S.
    Greer, Sarah C.
    Skinner, Robert B., Jr.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (04) : 189 - 194
  • [29] Safety concerns with salmeterol
    Wark, Peter A. B.
    AUSTRALIAN PRESCRIBER, 2006, 29 (05) : 118 - 119
  • [30] Nanoparticle safety concerns
    不详
    CHEMISTRY IN BRITAIN, 2003, 39 (11) : 8 - 8